» Articles » PMID: 931206

Pharmacokinetics of Lidocaine After Prolonged Intravenous Infusions in Uncomplicated Myocardial Infarction

Overview
Journal Ann Intern Med
Specialty General Medicine
Date 1977 Dec 1
PMID 931206
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

The kinetics of the elimination of lidocaine upon discontinuation of lidocaine infusions lasting more than 24 h were studied in 12 patients with uncomplicated myocardial infarctions. In this group of patients the mean half-life of the elimination phase was found to be 3.22 h. This is significantly different from the half-life of 100 min that has been reported after bolus injections or infusions lasting less than 12 h. This longer half-life should be taken into consideration in estimating the duration of toxicity and the rate of administration of the drug during and after intravenous infusions lasting 24 h or more.

Citing Articles

Intravenous lidocaine infusion as a component of multimodal analgesia for colorectal surgery-measurement of plasma levels.

Greenwood E, Nimmo S, PATERSON H, Homer N, Foo I Perioper Med (Lond). 2019; 8:1.

PMID: 30858969 PMC: 6390549. DOI: 10.1186/s13741-019-0112-4.


Population pharmacokinetics of lidocaine administered during and after cardiac surgery.

Hsu Y, Somma J, Newman M, Mathew J J Cardiothorac Vasc Anesth. 2011; 25(6):931-6.

PMID: 21616681 PMC: 3203309. DOI: 10.1053/j.jvca.2011.03.008.


Impact of intravenous lidocaine infusion on postoperative analgesia and recovery from surgery: a systematic review of randomized controlled trials.

McCarthy G, Megalla S, Habib A Drugs. 2010; 70(9):1149-63.

PMID: 20518581 DOI: 10.2165/10898560-000000000-00000.


Randomized, double-blinded, placebo controlled study of neuroprotection with lidocaine in cardiac surgery.

Mathew J, Mackensen G, Phillips-Bute B, Grocott H, Glower D, Laskowitz D Stroke. 2009; 40(3):880-7.

PMID: 19164788 PMC: 3718309. DOI: 10.1161/STROKEAHA.108.531236.


A population pharmacokinetic model of epidural lidocaine in geriatric patients: effects of low-dose dopamine.

Kwa A, Sprung J, Van Guilder M, Jelliffe R Ther Drug Monit. 2008; 30(3):379-89.

PMID: 18520611 PMC: 2724678. DOI: 10.1097/FTD.0b013e3181778fa3.